Treeman
Senior Member
- Messages
- 792
- Location
- York, England
A new UCLH and UCL-led observational study of patients with cerebral venous thrombosis (CVT) following COVID-19 vaccination provides a clearer guide to clinicians trying to diagnose and treat patients by giving more information about the characteristics of this condition when it is caused by the novel condition vaccine-induced immune thrombotic thrombocytopenia (VITT).
The study provides support for the three principles of treatment established so far by the Expert Haematology Panel, based on early work at UCLH and two other European sites:
1.The use of non-heparin-based anticoagulation
2.Give treatments to try to reduce the level of the abnormal antibody that is implicated in this condition, and
3.Avoid the strategy of trying to bring the platelet count back up to normal levels by giving platelet transfusions.
Study sheds light on treatment of rare cases of blood clotting in the brain following COVID-19 vaccination : University College London Hospitals NHS Foundation Trust (uclh.nhs.uk)
The study provides support for the three principles of treatment established so far by the Expert Haematology Panel, based on early work at UCLH and two other European sites:
1.The use of non-heparin-based anticoagulation
2.Give treatments to try to reduce the level of the abnormal antibody that is implicated in this condition, and
3.Avoid the strategy of trying to bring the platelet count back up to normal levels by giving platelet transfusions.
Study sheds light on treatment of rare cases of blood clotting in the brain following COVID-19 vaccination : University College London Hospitals NHS Foundation Trust (uclh.nhs.uk)